ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30+
SponsorBaylor Research Institute
About this trial
AI-Guided Coronary CT Angiography Screening in Former High-Intensity Athletes
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Former professional or collegiate high-intensity athletes (e.g., NFL alumni, Division I athletes, or equivalent competitive-level participants).
Age ≥30 years
Disqualifiers
eGFR <40 mL/min/1.73 m²
Known iodinated contrast allergy
Weight >450 lbs. (scanner table limit)
Inability to hold breath >10 seconds
Trial design
Design model
Single group
Treatments tested in this trial
Coronary CTA
DeviceThe Coronary CTA will be performed for each participant. These images will be analyzed using AI-software to assess plaque quantification and an ischemia analysis, if necessary.
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: AthletesExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Prevalence of Coronary Atherosclerosis
The primary outcome is to determine the prevalence of coronary atherosclerosis in former high-intensity athletes using AI-guided software to analyze a CCTA.
Time frame
At CCTA assessment2
Coronary Atherosclerosis Characteristics
Determine the characteristics (burden, composition, risk features) of coronary atherosclerosis in former high-intensity athletes using AI-guided software to analyze a CCTA.
Time frame
At CCTA AssessmentSecondary outcomes
1
Plaque Burden
The secondary outcome is to correlate plaque burden with biomarkers (Lipid panel, HbA1c).
Time frame
Day of CCTA and biomarker collectionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Baylor Research Institute
Lead sponsor
Cleerly, Inc.
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: